Logo image of ECOR

ELECTROCORE INC (ECOR) Stock Overview

USA - NASDAQ:ECOR - US28531P2020 - Common Stock

4.97 USD
-0.03 (-0.5%)
Last: 9/19/2025, 8:00:01 PM

ECOR Key Statistics, Chart & Performance

Key Statistics
52 Week High19.49
52 Week Low4.16
Market Cap37.67M
Shares7.58M
Float4.76M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.62
PEN/A
Fwd PEN/A
Earnings (Next)11-11 2025-11-11/amc
IPO06-22 2018-06-22
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ECOR short term performance overview.The bars show the price performance of ECOR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

ECOR long term performance overview.The bars show the price performance of ECOR in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of ECOR is 4.97 USD. In the past month the price decreased by -2.17%. In the past year, price decreased by -23.06%.

ELECTROCORE INC / ECOR Daily stock chart

ECOR Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.76 236.77B
ISRG INTUITIVE SURGICAL INC 54.5 157.27B
BSX BOSTON SCIENTIFIC CORP 34.57 144.96B
SYK STRYKER CORP 29.33 144.07B
MDT MEDTRONIC PLC 17.19 121.96B
BDX BECTON DICKINSON AND CO 13.11 53.61B
IDXX IDEXX LABORATORIES INC 54.63 52.49B
EW EDWARDS LIFESCIENCES CORP 28.95 43.69B
RMD RESMED INC 28.61 40.00B
GEHC GE HEALTHCARE TECHNOLOGY 16.08 34.20B
PHG KONINKLIJKE PHILIPS NVR- NY 16.52 27.05B
DXCM DEXCOM INC 39.68 26.45B

About ECOR

Company Profile

ECOR logo image electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 73 full-time employees. The company went IPO on 2018-06-22. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

Company Info

ELECTROCORE INC

200 Forge Way, Suite 205

Rockaway NEW JERSEY 07866 US

CEO: Daniel S. Goldberger

Employees: 73

ECOR Company Website

ECOR Investor Relations

Phone: 19732900097

ELECTROCORE INC / ECOR FAQ

What is the stock price of ELECTROCORE INC today?

The current stock price of ECOR is 4.97 USD. The price decreased by -0.5% in the last trading session.


What is the ticker symbol for ELECTROCORE INC stock?

The exchange symbol of ELECTROCORE INC is ECOR and it is listed on the Nasdaq exchange.


On which exchange is ECOR stock listed?

ECOR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ELECTROCORE INC stock?

10 analysts have analysed ECOR and the average price target is 21.5 USD. This implies a price increase of 332.63% is expected in the next year compared to the current price of 4.97. Check the ELECTROCORE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ELECTROCORE INC worth?

ELECTROCORE INC (ECOR) has a market capitalization of 37.67M USD. This makes ECOR a Nano Cap stock.


How many employees does ELECTROCORE INC have?

ELECTROCORE INC (ECOR) currently has 73 employees.


What are the support and resistance levels for ELECTROCORE INC (ECOR) stock?

ELECTROCORE INC (ECOR) has a support level at 4.83 and a resistance level at 5.61. Check the full technical report for a detailed analysis of ECOR support and resistance levels.


Is ELECTROCORE INC (ECOR) expected to grow?

The Revenue of ELECTROCORE INC (ECOR) is expected to grow by 22.37% in the next year. Check the estimates tab for more information on the ECOR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ELECTROCORE INC (ECOR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ELECTROCORE INC (ECOR) stock pay dividends?

ECOR does not pay a dividend.


When does ELECTROCORE INC (ECOR) report earnings?

ELECTROCORE INC (ECOR) will report earnings on 2025-11-11, after the market close.


What is the Price/Earnings (PE) ratio of ELECTROCORE INC (ECOR)?

ELECTROCORE INC (ECOR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.62).


What is the Short Interest ratio of ELECTROCORE INC (ECOR) stock?

The outstanding short interest for ELECTROCORE INC (ECOR) is 9.49% of its float. Check the ownership tab for more information on the ECOR short interest.


ECOR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ECOR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ECOR. While ECOR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ECOR Financial Highlights

Over the last trailing twelve months ECOR reported a non-GAAP Earnings per Share(EPS) of -1.62. The EPS increased by 26.03% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -91.02%
ROE -1190.57%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-15.79%
Sales Q2Q%20.23%
EPS 1Y (TTM)26.03%
Revenue 1Y (TTM)30.15%

ECOR Forecast & Estimates

10 analysts have analysed ECOR and the average price target is 21.5 USD. This implies a price increase of 332.63% is expected in the next year compared to the current price of 4.97.

For the next year, analysts expect an EPS growth of -4.2% and a revenue growth 22.37% for ECOR


Analysts
Analysts84
Price Target21.5 (332.6%)
EPS Next Y-4.2%
Revenue Next Year22.37%

ECOR Ownership

Ownership
Inst Owners18.57%
Ins Owners26.44%
Short Float %9.49%
Short Ratio4.2